Vaccine Innovation & Therapeutics
Accelerator Launchpad (VITAL)

Accelerating the Next Generation of Therapeutic and Vaccine Platforms and Technologies​

VITAL is a new accelerator hub in the U.S. Biomedical Advanced Research and Development Authority (BARDA) Accelerator Network (BAN). The BAN fosters growth of the global health security innovation ecosystem by supporting early-stage companies to overcome their business, marketing, and operational hurdles. VITAL supports development of next-generation therapeutic and vaccine technologies and platforms to promote health security, and is operated by Start2 Group, Advise Connect Inspire (ACI), and BioInnovation Labs (BioLabs).

VITAL Provides 3 Essential Services

Biotech Accelerator Programs

VITAL supports health security innovators, startups, and portfolio companies by providing wraparound accelerator services including entrepreneurship education and access to technical and business/commercialization expertise and resources.

Development, Evaluation, and Validation Awards

VITAL provides non-dilutive funding to startups to perform development, evaluation, and validation services for novel vaccine and therapeutic medical countermeasures that align with BARDA’s strategic priorities.

Rapid Response Capability

In the event of a Public Health Emergency, the BARDA Accelerator Network, including the VITAL Hub, can rapidly fund and accelerate product development and validation of medical countermeasures that can be developed and deployed as quickly as possible.

The Accelerator Program and DEV Awards are set to kick off in October of 2024.

The VITAL Biotech Accelerator Program

Are you a startup or university-based project pioneering the future of therapeutics and vaccines? We’re looking for innovative solutions that align with BARDA’s mission to enhance pandemic preparedness and health security. Apply to the VITAL Biotech Accelerator Program and make a global impact! Application Deadline: August 23.

Non-Dilutive Funding to Advance Your Therapeutic and Vaccine Innovations

Are you working on groundbreaking therapeutics or vaccine solutions? VITAL invites startups and university-backed projects to apply for non-dilutive funding ranging from $50K to $200K. This funding supports the development, evaluation, or validation of innovative solutions aligned with BARDA’s mission to enhance pandemic preparedness and health security. Application Deadline: August 23.

Mark Your Calendar!

BARDA VITAL Hub Symposium

June 27, 2024 at 2 PM CET | Berlin, Germany

Join us at the BARDA VITAL Hub Symposium in Berlin for cutting-edge insights on advancements in pandemic preparedness to combat infectious diseases and enhance global health security. Connect with global experts from the U.S., Canada, and EU to explore the latest discoveries and strategies in preventing and addressing global health crises.

Established by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS), the BARDA Accelerator Network (BAN) fosters the growth of health security innovation ecosystems globally and accelerates the development and commercialization of next-generation health security solutions.

BARDA Accelerator Network Hubs

Enabling Technologies
Launching soon
Digital Health Tools
Launching soon
Enabling Technologies
Launching soon